20028694

Source:http://linkedlifedata.com/resource/pubmed/id/20028694

Download in:

Switch to

Custom View

Named Graph Language Inference

Statements in which the resource exists as a subject.
Predicate	Object
rdf:type	pubmed:Citation
lifeskim:mentions	umls-concept:C0017262, umls-concept:C0018787, umls-concept:C0018810, umls-concept:C0039155, umls-concept:C0185117, umls-concept:C0205191, umls-concept:C0257190, umls-concept:C0286862, umls-concept:C0301630, umls-concept:C0332161, umls-concept:C0439851, umls-concept:C0441712, umls-concept:C0442805, umls-concept:C0443252, umls-concept:C0443254, umls-concept:C0542341, umls-concept:C1280500, umls-concept:C1314939, umls-concept:C1414618, umls-concept:C1552596, umls-concept:C1554184, umls-concept:C1947931, umls-concept:C2911684
pubmed:issue	12
pubmed:dateCreated	2010-6-15
pubmed:abstractText	To investigate the adaptations of left ventricular function and calcium handling to chronic heart rate reduction with ivabradine in the reperfused heart.
pubmed:commentsCorrections	http://linkedlifedata.com/resource/pubmed/commentcorrection/20028694-10830164, http://linkedlifedata.com/resource/pubmed/commentcorrection/20028694-10864882, http://linkedlifedata.com/resource/pubmed/commentcorrection/20028694-11157671, http://linkedlifedata.com/resource/pubmed/commentcorrection/20028694-11181013, http://linkedlifedata.com/resource/pubmed/commentcorrection/20028694-11397781, http://linkedlifedata.com/resource/pubmed/commentcorrection/20028694-12063272, http://linkedlifedata.com/resource/pubmed/commentcorrection/20028694-12193465, http://linkedlifedata.com/resource/pubmed/commentcorrection/20028694-14966299, http://linkedlifedata.com/resource/pubmed/commentcorrection/20028694-14981003, http://linkedlifedata.com/resource/pubmed/commentcorrection/20028694-15120055, http://linkedlifedata.com/resource/pubmed/commentcorrection/20028694-15197150, http://linkedlifedata.com/resource/pubmed/commentcorrection/20028694-16481613, http://linkedlifedata.com/resource/pubmed/commentcorrection/20028694-17141266, http://linkedlifedata.com/resource/pubmed/commentcorrection/20028694-17179940, http://linkedlifedata.com/resource/pubmed/commentcorrection/20028694-17188666, http://linkedlifedata.com/resource/pubmed/commentcorrection/20028694-17376788, http://linkedlifedata.com/resource/pubmed/commentcorrection/20028694-17384136, http://linkedlifedata.com/resource/pubmed/commentcorrection/20028694-18223669, http://linkedlifedata.com/resource/pubmed/commentcorrection/20028694-18252758, http://linkedlifedata.com/resource/pubmed/commentcorrection/20028694-18310678, http://linkedlifedata.com/resource/pubmed/commentcorrection/20028694-18621770, http://linkedlifedata.com/resource/pubmed/commentcorrection/20028694-18846042, http://linkedlifedata.com/resource/pubmed/commentcorrection/20028694-19074674, http://linkedlifedata.com/resource/pubmed/commentcorrection/20028694-19411283, http://linkedlifedata.com/resource/pubmed/commentcorrection/20028694-3815774, http://linkedlifedata.com/resource/pubmed/commentcorrection/20028694-7473152, http://linkedlifedata.com/resource/pubmed/commentcorrection/20028694-8032660
pubmed:language	eng
pubmed:journal	http://linkedlifedata.com/resource/pubmed/journal/8006263
pubmed:citationSubset	IM
pubmed:chemical	http://linkedlifedata.com/resource/pubmed/chemical/Anti-Arrhythmia Agents, http://linkedlifedata.com/resource/pubmed/chemical/Benzazepines, http://linkedlifedata.com/resource/pubmed/chemical/Calcium-Binding Proteins, http://linkedlifedata.com/resource/pubmed/chemical/Tacrolimus Binding Protein 1A, http://linkedlifedata.com/resource/pubmed/chemical/ivabradine
pubmed:status	MEDLINE
pubmed:month	Jun
pubmed:issn	1522-9645
pubmed:author	pubmed-author:BerdeauxAlainA, pubmed-author:BrunevalPatrickP, pubmed-author:ChetboulValérieV, pubmed-author:CouvreurNicolasN, pubmed-author:GhalehBijanB, pubmed-author:GouniVassilikyV, pubmed-author:MandetChantalC, pubmed-author:PonsSandrineS, pubmed-author:PouchelonJean-LouisJL, pubmed-author:TissierRenaudR
pubmed:issnType	Electronic
pubmed:volume	31
pubmed:owner	NLM
pubmed:authorsComplete	Y
pubmed:pagination	1529-37
pubmed:dateRevised	2011-7-27
pubmed:meshHeading	pubmed-meshheading:20028694-Animals, pubmed-meshheading:20028694-Anti-Arrhythmia Agents, pubmed-meshheading:20028694-Benzazepines, pubmed-meshheading:20028694-Blotting, Western, pubmed-meshheading:20028694-Calcium-Binding Proteins, pubmed-meshheading:20028694-Coronary Occlusion, pubmed-meshheading:20028694-Heart Rate, pubmed-meshheading:20028694-Myocardial Infarction, pubmed-meshheading:20028694-Myocardial Reperfusion, pubmed-meshheading:20028694-Rabbits, pubmed-meshheading:20028694-Stroke Volume, pubmed-meshheading:20028694-Tacrolimus Binding Protein 1A, pubmed-meshheading:20028694-Ventricular Dysfunction, Left
pubmed:year	2010
pubmed:articleTitle	Chronic heart rate reduction with ivabradine improves systolic function of the reperfused heart through a dual mechanism involving a direct mechanical effect and a long-term increase in FKBP12/12.6 expression.
pubmed:affiliation	INSERM U955 Equipe 03, 8, rue du Général Sarrail, Créteil F-94010, France.
pubmed:publicationType	Journal Article, Research Support, Non-U.S. Gov't